Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1361-1370 of 1,467) with videos related to

Pageof 147
Sort By:
Applied Health Economics and Health Policy|September 16, 2024
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of DiabetesTing Zhao, Michelle Tew, Talitha Feenstra, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.
Journal of Autoimmunity|December 30, 2019
Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritisLisa Göschl, Teresa Preglej, Nicole Boucheron, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes ChallengeLei Si, Michael S Willis, Christian Asseburg, et al.
Annals of the Rheumatic Diseases|September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controlsFelix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's SyndromeC Vitali, S Bombardieri, H M Moutsopoulos, et al.
Annals of the Rheumatic Diseases|March 23, 2013
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritisAlexandra N Colebatch, Christopher John Edwards, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|December 17, 2016
2016 update of the EULAR recommendations for the management of early arthritisBernard Combe, Robert Landewe, Claire I Daien, et al.
The Journal of Clinical Investigation|April 3, 2025
Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsAvy Violari, Kennedy Otwombe, William Hahn, et al.
Pageof 147

Showing results (1361-1370 of 1,467) with videos related to

Sort By:
Pageof 147
Applied Health Economics and Health Policy|September 16, 2024
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of DiabetesTing Zhao, Michelle Tew, Talitha Feenstra, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.
Journal of Autoimmunity|December 30, 2019
Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritisLisa Göschl, Teresa Preglej, Nicole Boucheron, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes ChallengeLei Si, Michael S Willis, Christian Asseburg, et al.
Annals of the Rheumatic Diseases|September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controlsFelix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's SyndromeC Vitali, S Bombardieri, H M Moutsopoulos, et al.
Annals of the Rheumatic Diseases|March 23, 2013
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritisAlexandra N Colebatch, Christopher John Edwards, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|December 17, 2016
2016 update of the EULAR recommendations for the management of early arthritisBernard Combe, Robert Landewe, Claire I Daien, et al.
The Journal of Clinical Investigation|April 3, 2025
Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsAvy Violari, Kennedy Otwombe, William Hahn, et al.
Pageof 147